ストックスクリーナーアプリを入手
70.33
2.05%
1.41
Tempus Ai Inc (TEM) 最新ニュース
Promising Artificial Intelligence Stocks To Follow TodayJanuary 4th - MarketBeat
Top Artificial Intelligence Stocks To Add to Your WatchlistJanuary 15th - MarketBeat
Best Artificial Intelligence Stocks To Watch NowJanuary 6th - MarketBeat
Tempus AI, Inc. Stock (TEM) Opinions on FDA Clearance and Financial Results - Quiver Quantitative
JPM26: Tempus AI and the push toward precision medicine - Yahoo Finance
Tempus AI approaching profitability despite GAAP losses - MSN
Why is Tempus AI stock surging 11% premarket today? - MSN
4 Hyper-Growth Stocks Ready to Dazzle This Earnings Season - Investing.com
Jobs Data: Is Tempus AI Inc stock a value trapPortfolio Growth Summary & High Return Trade Guides - baoquankhu1.vn
New Highs: Is Tempus AI Inc stock a value trapJuly 2025 Action & Fast Gaining Stock Reports - baoquankhu1.vn
Promising Artificial Intelligence Stocks To Watch TodayJanuary 13th - MarketBeat
Tempus AI (TEM) Soars 15% on $1.1-Billion Deal - Insider Monkey
TEM's Collab for Oncology Patient Population Is Gaining Attention - Yahoo Finance Singapore
Tempus AI, Inc. $TEM Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Lefkofsky sees more runway ahead for now-profitable Tempus - Crain's Chicago Business
SG Americas Securities LLC Sells 15,137 Shares of Tempus AI, Inc. $TEM - MarketBeat
Why Tempus AI Stock Jumped on Monday? - TradingView — Track All Markets
Is Tempus AI (TEM) Pricing Reflect Its AI Healthcare Story After Strong 1 Year Run? - Yahoo Finance
Tempus AI achieved a record $1.1B in contracts for 2025 - Investorsobserver
Nvidia and Tempus drive AI transformation in Korea-linked drug discovery and manufacturingCHOSUNBIZ - Chosunbiz
Why Tempus AI Stock Rose Today - Finviz
Record 2025 Revenue and New Cancer Data Deals Might Change The Case For Investing In Tempus AI (TEM) - simplywall.st
Why Tempus AI stock rose today - MSN
JPM26, Day 1: Waystar rolls out agentic AI; Intermountain CEO addresses political upheaval - Fierce Healthcare
JPM Kicks Off With Alnylam In the Red; But Others Surge - Investor's Business Daily
Tempus AI (NASDAQ:TEM) Shares Gap UpStill a Buy? - MarketBeat
Why Tempus AI Stock Is Trading Higher On Monday? - Benzinga
Tempus Shares Jump After Strong Preliminary 2025 Results - Yahoo Finance
Tempus AI's Pharma Momentum Accelerates - GuruFocus
Northwestern Medicine Selects Tempus AI, Inc. to Expand Genomic Testing - marketscreener.com
Tempus and NYU Langone partner on cancer genomic research - Investing.com
Tempus and NYU Langone partner on cancer genomic research By Investing.com - Investing.com South Africa
Promising Artificial Intelligence Stocks To Keep An Eye OnJanuary 12th - MarketBeat
Here’s why the Tempus AI stock may surge 47% soon - CryptoRank
Nancy Pelosi's Latest Trades Are Heating Up — Tempus AI's 100% Stock Surge Is Leading The Charge - Benzinga
Tempus AI rises on better-than-expected sales numbers - Sherwood News
Tempus Pre Announcing Strong Data (NASDAQ:TEM) - Seeking Alpha
Tempus AI shares jump after company posts record $1.1BN contract backlog - MSN
Why Is Tempus AI Stock Surging 11% Premarket Today? - Menafn
Tempus AI stock pops 12% premarket after $1.1 billion contracts update — what traders watch next - TechStock²
Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology - Business Wire
Tempus AI (TEM) Stock: Why Big Pharma Is Betting Big on This AI Platform - Blockonomi
Tempus AI Stock Rallies 105% in a Year: Should Investors Still Hold? - Yahoo Finance
Northwestern Medicine and Tempus partner to expand cancer genomic testing - Investing.com Canada
S&P 500 Futures Fall in Premarket Trading; Tempus AI, Klarna Group Lead - Barron's
Northwestern Medicine and Tempus partner to expand cancer genomic testing By Investing.com - Investing.com South Africa
Tempus AI stock soars after achieving record $1.1 billion contract value - Investing.com Nigeria
Tempus AI stock soars after achieving record $1.1 billion contract value By Investing.com - Investing.com South Africa
Northwestern Medicine Selects Tempus to Expand Genomic Testing - The Joplin Globe
Tempus AI Reports Strong Preliminary 2025 Revenue Growth - TipRanks
Tempus AI climbs on $1.1 billion contract value - TradingView — Track All Markets
Tempus AI stock jumps in premarket after $1.27 billion revenue preview, contract value tops $1.1 billion - TechStock²
0.51%
1.81%
大文字化:
|
ボリューム (24 時間):